1 Value Stock Worth Investigating and 2 That Underwhelm

1 Value Stock Worth Investigating and 2 That Underwhelm

Adam Hejl

Tue, February 24, 2026 at 1:38 PM GMT+9 3 min read

In this article:

CNXC

-9.35%

ASGN

-9.52%

CROX

-3.39%

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.

Identifying genuine bargains from value traps is something many investors struggle with, which is why we started StockStory - to help you find the best companies. That said, here is one value stock offering a compelling risk-reward profile and two with little support.

Two Value Stocks to Sell:

Crocs (CROX)

Forward P/E Ratio: 7.5x

Founded in 2002, Crocs (NASDAQ:CROX) sells casual footwear and is known for its iconic clog shoe.

Why Do We Think CROX Will Underperform?

Constant currency growth was below our standards over the past two years, suggesting it might need to invest in product improvements to get back on track

Free cash flow margin is anticipated to expand by 1.8 percentage points over the next year, providing additional flexibility for investments and share buybacks/dividends

Waning returns on capital from an already weak starting point displays the inefficacy of management’s past and current investment decisions

Crocs is trading at $96.89 per share, or 7.5x forward P/E. Read our free research report to see why you should think twice about including CROX in your portfolio, it’s free.

ASGN (ASGN)

Forward P/E Ratio: 9x

Evolving from its roots in IT staffing to become a high-end technology consulting powerhouse, ASGN (NYSE:ASGN) provides specialized IT consulting services and staffing solutions to Fortune 1000 companies and U.S. federal government agencies.

Why Do We Pass on ASGN?

Sales tumbled by 5.4% annually over the last two years, showing market trends are working against its favor during this cycle

Projected sales growth of 1.2% for the next 12 months suggests sluggish demand

Falling earnings per share over the last five years has some investors worried as stock prices ultimately follow EPS over the long term

At $40.96 per share, ASGN trades at 9x forward P/E. Check out our free in-depth research report to learn more about why ASGN doesn’t pass our bar.

One Value Stock to Watch:

Concentrix (CNXC)

Forward P/E Ratio: 2.8x

With a team of approximately 450,000 employees across 75 countries, Concentrix (NASDAQ:CNXC) designs and delivers customer experience solutions that help global brands manage their customer interactions across digital channels and contact centers.

Why Does CNXC Stand Out?

Market share has increased this cycle as its 17.5% annual revenue growth over the last two years was exceptional

Economies of scale give it some operating leverage when demand rises

Respectable free cash flow margin of 6% minimizes the need for external capital because it can finance growth internally

 






Story Continues  

Concentrix’s stock price of $30.41 implies a valuation ratio of 2.8x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free.

High-Quality Stocks for All Market Conditions

Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.

The names generating the next wave of massive growth are right here in our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.

Terms and Privacy Policy

Privacy Dashboard

More Info